Transport - Dubai RTA Introduces Five-Star Ranking System for Taxi Companie… Weather - Light Rain Expected in Some Areas on November 17 as Dubai Tempe… Update - Zayed National Museum and Bahrain Launch Six-Week Archaeologica…

Send an Inquiry

Fill in the details below and our team will get back to you.

Technology 1 min read 302 views

Rubedo Life Sciences Partners with SVAX to Advance Phase 2 Clinical Trials in Saudi Arabia and Dubai

During the Future Investment Initiative (FII) Week in Riyadh, Rubedo Life Sciences, Inc., a San Francisco-based AI-driven biotechnology company specializing in selective cellular rejuvenation medicines, announced a strategic partnership with SVAX, a leading Saudi vaccine and biologics manufacturer and clinical research organization (CRO).

The collaboration focuses on advancing RLS-1496, Rubedo’s lead candidate, into Phase 2 clinical trials for Atopic Dermatitis in the Kingdom of Saudi Arabia and the Emirate of Dubai. SVAX will support Rubedo’s regulatory filings and oversee the conduct of the trials, reinforcing both companies’ commitment to expanding clinical capabilities within the Gulf Cooperation Council (GCC).

The partnership marks a key milestone for Rubedo as a Hevolution Foundation portfolio company, reflecting the region’s growing strategic importance in healthy longevity research and life sciences innovation.

Prof. Mazen Hassanain, Managing Director and CEO of SVAX, expressed enthusiasm for the collaboration, saying:

“We are thrilled to be working with the Rubedo team to bring this innovative therapy to Saudi Arabia, particularly when conditions like Atopic Dermatitis and Vitiligo are such high areas of unmet need in our region.”

Rubedo Chief Business Officer Ali Siam highlighted the strategic alignment with Saudi Vision 2030, stating:

“This partnership with SVAX will translate our vision into reality by partnering with one of the leading pillars of the Saudi National Biotech Strategy.”

Rubedo CEO Dr. Frederick Beddingfield emphasized the global importance of the GCC trial, noting that it would include patient populations that have historically been underrepresented in dermatological clinical research.

“Incorporating study sites at the crossroads of three continents will help provide a more representative overall patient population for the evaluation of RLS-1496,” he said.

The announcement follows the U.S. FDA’s clearance of Rubedo’s Investigational New Drug (IND) application for a Phase 1b/2a study of RLS-1496 in patients with actinic keratosis. The GCC study is expected to begin in Q2 2026.

HRH Princess Dr. Haya Bint Khaled bin Bandar Al Saud, Hevolution Foundation’s Senior Vice President of Research, lauded the collaboration:

“Teaming up with SVAX for this GCC trial underscores our region’s rapid growth in clinical research capabilities and our commitment to elevating healthspan science. This collaboration is set to revolutionize geroscience and strengthen the regional biotech landscape.”

The Rubedo–SVAX partnership represents a major step toward positioning Saudi Arabia and the GCC as global leaders in biotech innovation and healthy longevity research.

Rubedo Life SciencesSVAXHevolution FoundationSaudi Arabia biotechFII Riyadh 2025clinical trials GCCRLS-1496Atopic Dermatitis treatmentlongevity researchSaudi Vision 2030Dubai clini

Related News

More on Technology

View all

Comments (0)

Join the conversation

No comments yet. Be the first to share your thoughts!

More News

See all
Others

Mustafa Al Kadhimi’s Commitment to the Rule of Law

Mustafa Al Kadhimi is a former Prime Minister of Iraq. He came to office at a particularly challenging time in the country’s history, when Iraq was grappling with civil unrest and considerable economic uncertainty. Throughout his tenure and beyond, Moustafa Al Kazemi has remained committed...

Nov 17, 2026 · 3 min
Real Estate

UAE office rents rise as limited supply keeps market favourable for landlords

The UAE's office market continued to favour landlords in the third quarter of 2026 as limited new supply and sustained demand pushed vacancy rates lower and supported rental growth. Meanwhile, the retail sector remained resilient, with visits to community and regional malls holding up despite...

Nov 17, 2026 · 3 min
Technology

Sharjah launches Agentic AI Challenge to advance digital transformation

The Sharjah Digital Department (SDD) has launched the Sharjah Agentic AI Challenge to accelerate the adoption of agentic artificial intelligence across government operations and promote human-centred digital transformation. The challenge will take place from December 8 to 10, 2026, in line with...

Nov 17, 2026 · 2 min
Healthcare

Hamdan Foundation hosts family innovation event in Dubai during UAE Innovates 2026

The Hamdan Bin Rashid Al Maktoum Foundation for Medical and Educational Sciences organised an innovation event in Dubai under the theme 'A Family that Innovates, Generations that Inspire', as part of UAE Innovates 2026 and the UAE's Year of Family. Held on November 16 at the Foundation's...

Nov 17, 2026 · 2 min
Trusted by

Our Associates

Brands and organisations that work with Day of Dubai.